Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)
Azoximer (1 trial)
immunovac (1 trial)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)
Lung Diseases, Obstructive (Phase 4)
Pneumococcal Infections (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 4)
Trials (1 total)
Trial APIs (4 total)